New Compounds Force Pancreatic Cancer Cells to Self-Destruct by Overloading Their Own Signals
Experimental PCAI compounds blocked over 90% of pancreatic cancer cell migration and triggered self-destruction by hyperactivating tumor growth pathways.
1,333 articles
Experimental PCAI compounds blocked over 90% of pancreatic cancer cell migration and triggered self-destruction by hyperactivating tumor growth pathways.
A 2-year USC clinical trial found DHA supplements reached the brain but failed to improve memory or slow Alzheimer's-related brain changes.
A new monoclonal antibody drug shows significant eye bulging reduction and double-vision relief for both active and chronic thyroid eye disease.
A VA study of 2.5 million people finds coadministering COVID and flu vaccines on the same day is as safe as getting a flu shot alone.
New research finds years smoked — not pack-years — may better identify who benefits most from low-dose CT lung cancer screening.
A Hong Kong sibling-matched cohort study finds acetaminophen during pregnancy unlikely to cause autism or ADHD in children.
Scientists identify a primate-specific long non-coding RNA that accelerates cellular aging, opening new targets for senescence intervention.
LyGenesis wins funding to develop immune tolerance for pancreatic islet transplants, using its novel lymph node organ-growing platform.
Generation Lab's updated test measures 460+ biomarkers with separate male and female analyses, tracking organ aging and treatment response.
NeuroSense's oral drug combination shifted key Alzheimer's proteins in a small Phase 2 trial, with no serious safety concerns reported.
Verge Labs is training AI on 12,000+ human brain samples to predict which drugs work for which patients before costly trials begin.
A new AI-powered platform combines genetics, hormones, and lifestyle data to assess 130+ female-specific conditions before they worsen.